Skip to main content
. 2019 Jul 1;179(8):1034–1042. doi: 10.1001/jamainternmed.2019.0981

Table 2. Baseline Demographic and Clinical Characteristics of Patients With Hyperthyroidism Treated With Radioactive Iodine.

Baseline Characteristics Tertile of Total Administered Activity, MBq
1 (n = 6296) 2 (n = 6248) 3 (n = 6261)
Total administered activity, mean (SD), MBqa 160 (45) 289 (46) 724 (500)
No. of RAI treatments, mean (SD) 1.3 (1.2) 1.4 (0.9) 2.4 (1.9)
Dose, mGy
Stomach 65 (20) 120 (25) 320 (240)
Breastb 60 (21) 110 (29) 280 (210)
Thyroid 65 000 (31 000) 110 000 (41 000) 210 000 (160 000)
Study entry age, mean (SD), y 47 (13) 49 (14) 52 (14)
Sex, No. (%)
Male 1288 (20.5) 1383 (22.1) 1463 (23.4)
Female 5008 (79.5) 4865 (77.9) 4798 (76.6)
Clinical impression, No. (%)
Suspect 111 (1.8) 96 (1.5) 72 (1.2)
Mild 1758 (27.9) 1649 (26.4) 1567 (25.0)
Moderate 2564 (40.7) 2605 (41.7) 2639 (42.2)
Severe 439 (7.0) 596 (9.5) 857 (13.7)
Unknown 1424 (22.6) 1301 (20.8) 1126 (18.0)
Type of hyperthyroidism, No. (%)
Graves disease 6127 (97.3) 5967 (95.5) 5521 (88.2)
Toxic nodular goiter 115 (1.8) 207 (3.3) 612 (9.8)
Intermediate status 54 (0.9) 74 (1.2) 128 (2.0)
Weight loss prior to surgical procedure, No. (%) 4165 (66.2) 3995 (63.9) 3911 (62.5)
Amount of weight loss prior to surgical procedure, mean (SD), lb 19 (13) 21 (14) 23 (16)
Medical history (prior to surgical procedure), No. (%)
Coronary heart disease 257 (4.1) 442 (7.1) 654 (10.5)
Hypertensive heart disease 364 (5.8) 564 (9.0) 720 (11.5)
Rheumatic heart disease 137 (2.2) 191 (3.1) 222 (3.6)
Other heart disease 274 (4.4) 398 (6.4) 718 (11.5)
Diabetes 238 (3.8) 303 (4.9) 433 (6.9)
Treatment combinations, No. (%)
RAI only 2589 (41.1) 2597 (41.6) 1996 (31.9)
RAI and surgical procedure 278 (4.4) 225 (3.6) 191 (3.1)
RAI and drugs 798 (12.5) 726 (11.6) 739 (11.8)
RAI, surgical procedure, and drugs 2640 (41.9) 2700 (43.2) 3335 (53.3)

Abbreviations: MBq, megabecquerel; RAI, radioactive iodine.

SI conversion factors: To convert pounds to kg, multiply by 0.45.

a

Includes diagnostic and therapeutic doses.

b

Women only.